bluebird bio Statistics
Total Valuation
CDAB has a market cap or net worth of 33.42 million.
| Market Cap | 33.42M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, July 17, 2025.
| Earnings Date | Jul 17, 2025 |
| Ex-Dividend Date | Jan 31, 2025 |
Share Statistics
CDAB has 1.88 million shares outstanding. The number of shares has decreased by -2.61% in one year.
| Current Share Class | 1.88M |
| Shares Outstanding | 1.88M |
| Shares Change (YoY) | -2.61% |
| Shares Change (QoQ) | -2.95% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 24.90.
| PE Ratio | 24.90 |
| Forward PE | n/a |
| PS Ratio | 3.85 |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 5.77%.
| Return on Equity (ROE) | 5.77% |
| Return on Assets (ROA) | 0.57% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CDAB has paid 368,776 in taxes.
| Income Tax | 368,776 |
| Effective Tax Rate | 21.72% |
Stock Price Statistics
The stock price has increased by +42.00% in the last 52 weeks. The beta is 0.25, so CDAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +42.00% |
| 50-Day Moving Average | 16.39 |
| 200-Day Moving Average | 12.67 |
| Relative Strength Index (RSI) | 50.80 |
| Average Volume (20 Days) | 2,433 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, CDAB had revenue of 8.69 million and earned 1.33 million in profits. Earnings per share was 0.71.
| Revenue | 8.69M |
| Gross Profit | 8.69M |
| Operating Income | 1.70M |
| Pretax Income | 1.70M |
| Net Income | 1.33M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.71 |
Balance Sheet
The company has 11.53 million in cash and 1.42 million in debt, giving a net cash position of 10.11 million or 5.37 per share.
| Cash & Cash Equivalents | 11.53M |
| Total Debt | 1.42M |
| Net Cash | 10.11M |
| Net Cash Per Share | 5.37 |
| Equity (Book Value) | 24.42M |
| Book Value Per Share | 13.10 |
| Working Capital | -183.90M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 19.55% |
| Pretax Margin | 19.55% |
| Profit Margin | 15.30% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.13%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 2.61% |
| Shareholder Yield | 3.74% |
| Earnings Yield | 3.98% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |